JP2017525671A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017525671A5 JP2017525671A5 JP2017500060A JP2017500060A JP2017525671A5 JP 2017525671 A5 JP2017525671 A5 JP 2017525671A5 JP 2017500060 A JP2017500060 A JP 2017500060A JP 2017500060 A JP2017500060 A JP 2017500060A JP 2017525671 A5 JP2017525671 A5 JP 2017525671A5
- Authority
- JP
- Japan
- Prior art keywords
- particles
- micronized
- diameter
- walton
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 claims 13
- 239000000203 mixture Substances 0.000 claims 7
- 239000000084 colloidal system Substances 0.000 claims 3
- 239000000499 gel Substances 0.000 claims 3
- 239000003292 glue Substances 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 238000002399 angioplasty Methods 0.000 claims 1
- 239000008365 aqueous carrier Substances 0.000 claims 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims 1
- 239000010419 fine particle Substances 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 235000015110 jellies Nutrition 0.000 claims 1
- 239000008274 jelly Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 239000002953 phosphate buffered saline Substances 0.000 claims 1
- 210000005059 placental tissue Anatomy 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462022084P | 2014-07-08 | 2014-07-08 | |
| US62/022,084 | 2014-07-08 | ||
| PCT/US2015/039444 WO2016007554A1 (en) | 2014-07-08 | 2015-07-07 | Micronized wharton's jelly |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017525671A JP2017525671A (ja) | 2017-09-07 |
| JP2017525671A5 true JP2017525671A5 (enExample) | 2018-08-16 |
| JP6640826B2 JP6640826B2 (ja) | 2020-02-05 |
Family
ID=55064792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017500060A Active JP6640826B2 (ja) | 2014-07-08 | 2015-07-07 | 微粒子化ワルトン膠質 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20160008410A1 (enExample) |
| EP (1) | EP3167049A4 (enExample) |
| JP (1) | JP6640826B2 (enExample) |
| AU (1) | AU2015287920A1 (enExample) |
| WO (1) | WO2016007554A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2999420A1 (en) | 2005-09-27 | 2007-04-05 | Tissuetech, Inc. | Amniotic membrane preparations and purified compositions and methods of use |
| WO2012149486A1 (en) | 2011-04-28 | 2012-11-01 | Tissuetech, Inc. | Methods of modulating bone remodeling |
| ES2822301T3 (es) | 2011-06-10 | 2021-04-30 | Tissuetech Inc | Métodos de procesamiento de tejidos de soporte fetal |
| TW201603818A (zh) | 2014-06-03 | 2016-02-01 | 組織科技股份有限公司 | 組成物及方法 |
| WO2016111899A1 (en) | 2015-01-05 | 2016-07-14 | Petrucci Gary M | Methods and materials for treating lung disorders |
| US20160243288A1 (en) | 2015-02-23 | 2016-08-25 | Tissuetech, Inc. | Apparatuses and methods for treating ophthalmic diseases and disorders |
| EP3297645A4 (en) | 2015-05-20 | 2018-12-12 | Tissuetech, Inc. | Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
| TW201733600A (zh) | 2016-01-29 | 2017-10-01 | 帝聖工業公司 | 胎兒扶持組織物及使用方法 |
| WO2017136557A1 (en) | 2016-02-05 | 2017-08-10 | Petrucci Gary M | Methods and materials for treating nerve injuries and neurological disorders |
| US10463699B2 (en) | 2016-04-04 | 2019-11-05 | Omeza LLC | Fish oil topical composition |
| US10478531B2 (en) * | 2017-06-22 | 2019-11-19 | Gary M. Petrucci | Methods and materials for treating blood vessels |
| US10251917B1 (en) | 2017-09-19 | 2019-04-09 | Gary M. Petrucci | Methods and materials for treating tumors |
| US20220152120A1 (en) * | 2019-04-16 | 2022-05-19 | Lifenet Health | Birth tissue-derived products and preparation and uses thereof |
| US20220280573A1 (en) * | 2021-03-03 | 2022-09-08 | Axogen Corporation | Human umbilical cord-derived compositions and uses thereof for treating neuropathy |
| WO2022186946A1 (en) * | 2021-03-03 | 2022-09-09 | Axogen Corporation | Human umbilical cord-derived compositions and uses thereof for treating neuropathy |
| JP2025507011A (ja) * | 2022-03-01 | 2025-03-13 | 国立陽明交通大学 | 骨再生を促進するための、ワルトンゼリーから製造される医薬製品 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2453638A1 (fr) | 1979-04-10 | 1980-11-07 | Bontemps Raymond | Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele |
| US5206023A (en) * | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
| CA2060223C (en) * | 1991-02-12 | 1999-07-20 | Clarence C. Lee | Injectable medical lubricating fluid composition and method of use |
| US5558071A (en) | 1994-03-07 | 1996-09-24 | Combustion Electromagnetics, Inc. | Ignition system power converter and controller |
| US5919702A (en) * | 1996-10-23 | 1999-07-06 | Advanced Tissue Science, Inc. | Production of cartilage tissue using cells isolated from Wharton's jelly |
| IL134830A0 (en) | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| JP2003526671A (ja) | 2000-03-14 | 2003-09-09 | レストラゲン，インコーポレイテッド | 幽門洞−十二指腸運動性に対するグルカゴン様ペプチド‐１（７−３６）の作用 |
| ES2672815T3 (es) * | 2001-10-18 | 2018-06-18 | Lifecell Corporation | Remodelación de tejidos y órganos |
| ES2363978T3 (es) | 2004-02-13 | 2011-08-22 | Cognis France, S.A.S. | Uso de composiciones cosméticas que comprenden un extracto de las hojas de castanea sativa. |
| US9005646B2 (en) | 2005-10-12 | 2015-04-14 | Lifenet Health | Compositions for repair of defects in tissues, and methods of making the same |
| WO2008021391A1 (en) | 2006-08-15 | 2008-02-21 | Anthrogenesis Corporation | Umbilical cord biomaterial for medical use |
| US8372437B2 (en) | 2006-08-17 | 2013-02-12 | Mimedx Group, Inc. | Placental tissue grafts |
| WO2008037082A1 (en) | 2006-09-25 | 2008-04-03 | Archer-Daniels-Midland Company | Superabsorbent surface-treated carboxyalkylated polysaccharides and process for producing same |
| US8071135B2 (en) | 2006-10-04 | 2011-12-06 | Anthrogenesis Corporation | Placental tissue compositions |
| EP2197270B8 (en) | 2007-09-07 | 2020-03-04 | Surgical Biologics, LLC | Placental tissue grafts and improved methods of preparing and using the same |
| AU2009296734B2 (en) | 2008-09-25 | 2016-02-18 | Cephalon Llc | Liquid formulations of bendamustine |
| CN102176881B (zh) * | 2008-10-10 | 2014-12-10 | 海斯特赛尔有限公司 | 来自人脐带的脐带胶质的新生物材料 |
| ES2767252T3 (es) | 2009-08-25 | 2020-06-17 | Tissue Tech Inc | Productos de la membrana amniótica del cordón umbilical |
| CN102198292B (zh) | 2010-03-26 | 2013-06-26 | 卢世璧 | 组织工程用脐带去细胞Wharton胶支架及其制备方法 |
| WO2012112410A2 (en) | 2011-02-14 | 2012-08-23 | Mimedx Group Inc. | Micronized placental tissue compositions and methods for making and using the same |
| CA2826433C (en) | 2011-02-14 | 2022-05-31 | Brenda S. Morse | Micronized placental tissue compositions and methods of making and using the same |
| WO2012112441A1 (en) * | 2011-02-14 | 2012-08-23 | Mimedx Group Inc. | Laminated tissue grafts composed of wharton's jelly and methods of making and using the same |
| WO2012149486A1 (en) | 2011-04-28 | 2012-11-01 | Tissuetech, Inc. | Methods of modulating bone remodeling |
| CA2842690A1 (en) * | 2011-07-27 | 2013-01-31 | Polyone Corporation | Crosslinkable bioplasticizers |
| US12290613B2 (en) * | 2011-10-06 | 2025-05-06 | Mimedx Group, Inc. | Micronized compositions composed of bone grafts and methods of making and using the same |
| SI3321355T1 (sl) | 2011-12-30 | 2021-11-30 | Amit Patel | Postopki in sestavki za klinično izpeljavo alogenske celice in terapevtske uporabe |
| US8904664B2 (en) | 2012-08-15 | 2014-12-09 | Mimedx Group, Inc. | Dehydration device and methods for drying biological materials |
| US9943551B2 (en) | 2012-08-15 | 2018-04-17 | Mimedx Group, Inc. | Tissue grafts composed of micronized placental tissue and methods of making and using the same |
| US11338063B2 (en) * | 2012-08-15 | 2022-05-24 | Mimedx Group, Inc. | Placental tissue grafts modified with a cross-linking agent and methods of making and using the same |
| WO2014028657A1 (en) | 2012-08-15 | 2014-02-20 | Mimedx Group, Inc | Reinforced placental tissue grafts and methods of making and using the same |
| US20140106447A1 (en) | 2012-10-12 | 2014-04-17 | Mimedx Group, Inc. | Compositions and methods for recruiting stem cells |
| US10449220B2 (en) * | 2013-08-30 | 2019-10-22 | Mimedx Group, Inc. | Micronized placental compositions comprising a chelator |
| AU2015264025A1 (en) * | 2014-05-21 | 2016-12-01 | Mimedx Group, Inc. | Micronized Wharton's jelly |
| US20160000968A1 (en) | 2014-07-07 | 2016-01-07 | Mimedx Group, Inc. | Placental tissue grafts and improved methods of preparing and using the same |
-
2015
- 2015-07-07 JP JP2017500060A patent/JP6640826B2/ja active Active
- 2015-07-07 US US14/793,673 patent/US20160008410A1/en not_active Abandoned
- 2015-07-07 EP EP15819525.5A patent/EP3167049A4/en not_active Withdrawn
- 2015-07-07 WO PCT/US2015/039444 patent/WO2016007554A1/en not_active Ceased
- 2015-07-07 AU AU2015287920A patent/AU2015287920A1/en not_active Abandoned
-
2016
- 2016-05-26 US US15/166,016 patent/US10307443B2/en active Active
-
2019
- 2019-04-18 US US16/388,334 patent/US20190307812A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017525671A5 (enExample) | ||
| Sharma et al. | An insight into functionalized calcium based inorganic nanomaterials in biomedicine: Trends and transitions | |
| JP2017517255A5 (enExample) | ||
| AU2015287920A8 (en) | Micronized Wharton's Jelly | |
| MX384021B (es) | Composiciones y metodos para aplicaciones oftalmicas y/u otras aplicaciones. | |
| JP2014240439A5 (enExample) | ||
| JP2016504362A5 (enExample) | ||
| MX2009012279A (es) | Distribucion de micro y nanoparticulas con plaquetas. | |
| WO2017100700A3 (en) | Peptides for renal therapy | |
| WO2015050814A3 (en) | Therapeutic agents for delivery using a catheter and pressure source | |
| JP2014000094A5 (ja) | 臍帯由来細胞を用いた局部的または散在的脳外傷の改善 | |
| SG10201808104RA (en) | Cenicriviroc for the treatment of fibrosis | |
| PH12017500479A1 (en) | Liquid inhalation formulation comprising prl554 | |
| BR112013027674A2 (pt) | "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha". | |
| MX340962B (es) | Agentes de enlace a receptor de canabinoide, composiciones y metodos. | |
| IL294463A (en) | Methods for treating or preventing eye conditions | |
| BR112015018252A2 (pt) | composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit | |
| JP2014509319A5 (enExample) | ||
| JP2014218522A5 (enExample) | ||
| Gomzikova et al. | Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells | |
| JP2013544781A5 (enExample) | ||
| WO2016095013A8 (en) | Pharmaceutical composition comprising plasminogen and uses thereof | |
| EP4249431A3 (en) | Compositions and methods for treating diseases or disorders using extended release nitric oxide releasing solutions | |
| JP2015505541A5 (enExample) | ||
| RU2016132762A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением |